Interferon Regulatory Factor-1 (IRF-1) Shapes Both Innate and CD8(+) T Cell Immune Responses Against West Nile Virus Infection

Overview

Journal PLoS Pathog

Specialty Microbiology

Date 2011 Sep 13

PMID 21909274

Citations 61

Authors

James D Brien

Stephane Daffis

Helen M Lazear

Hyelim Cho

Mehul S Suthar

Michael Gale Jr

Michael S Diamond

Affiliations

Soon will be listed here.

Abstract

Interferon regulatory factor (IRF)-1 is an immunomodulatory transcription factor that functions downstream of pathogen recognition receptor signaling and has been implicated as a regulator of type I interferon (IFN)-αβ expression and the immune response to virus infections. However, this role for IRF-1 remains controversial because altered type I IFN responses have not been systemically observed in IRF-1(-/-) mice. To evaluate the relationship of IRF-1 and immune regulation, we assessed West Nile virus (WNV) infectivity and the host response in IRF-1(-/-) cells and mice. IRF-1(-/-) mice were highly vulnerable to WNV infection with enhanced viral replication in peripheral tissues and rapid dissemination into the central nervous system. Ex vivo analysis revealed a cell-type specific antiviral role as IRF-1(-/-) macrophages supported enhanced WNV replication but infection was unaltered in IRF-1(-/-) fibroblasts. IRF-1 also had an independent and paradoxical effect on CD8(+) T cell expansion. Although markedly fewer CD8(+) T cells were observed in naïve animals as described previously, remarkably, IRF-1(-/-) mice rapidly expanded their pool of WNV-specific cytolytic CD8(+) T cells. Adoptive transfer and in vitro proliferation experiments established both cell-intrinsic and cell-extrinsic effects of IRF-1 on the expansion of CD8(+) T cells. Thus, IRF-1 restricts WNV infection by modulating the expression of innate antiviral effector molecules while shaping the antigen-specific CD8(+) T cell response.

Citing Articles

Harnessing defective interfering particles and lipid nanoparticles for effective delivery of an anti-dengue virus RNA therapy.

Lin M, Maniam P, Li D, Tang B, Bishop C, Suhrbier A Mol Ther Nucleic Acids. 2025; 36(1):102424.

PMID: 39817192 PMC: 11733052. DOI: 10.1016/j.omtn.2024.102424.

lncRNA regulates expression and function of innate immune transcription factor IRF1 in macrophages.

Cyr Y, Gourvest M, Ciabattoni G, Zhang T, Newman A, Zahr T Life Sci Alliance. 2025; 8(3).

PMID: 39773901 PMC: 11707381. DOI: 10.26508/lsa.202403021.

A sort and sequence approach to dissect heterogeneity of response to a self-amplifying RNA vector in a novel human muscle cell line.

Barton R, Tregoning J, Wang Z, Goncalves-Carneiro D, Patel R, McKay P Mol Ther Nucleic Acids. 2025; 36(1):102400.

PMID: 39759876 PMC: 11700297. DOI: 10.1016/j.omtn.2024.102400.

Role of Interferon Regulatory Factor 1 in acute and chronic virus infections.

Rahlf C, Tarakanova V Virology. 2025; 603:110386.

PMID: 39754861 PMC: 11788042. DOI: 10.1016/j.virol.2024.110386.

Fate induction in CD8 CAR T cells through asymmetric cell division.

Lee C, Chen S, Berry C, Kelly A, Herman P, Oh S Nature. 2024; 633(8030):670-677.

PMID: 39198645 PMC: 11410665. DOI: 10.1038/s41586-024-07862-7.

References

White L, Wright K, Felix N, Ruffner H, Reis L, Pine R . Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. Immunity. 1996; 5(4):365-76. DOI: 10.1016/s1074-7613(00)80262-9. View

Noah D, Stewart M, Blum M, Sherry B . Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis. Virology. 2002; 298(1):20-9. DOI: 10.1006/viro.2002.1470. View

Saha B, Prasanna S, Chandrasekar B, Nandi D . Gene modulation and immunoregulatory roles of interferon gamma. Cytokine. 2009; 50(1):1-14. DOI: 10.1016/j.cyto.2009.11.021. View

Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, Hida S . Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity. 1997; 6(6):673-9. DOI: 10.1016/s1074-7613(00)80443-4. View

Fuchs A, Pinto A, Schwaeble W, Diamond M . The lectin pathway of complement activation contributes to protection from West Nile virus infection. Virology. 2011; 412(1):101-9. PMC: 3057364. DOI: 10.1016/j.virol.2011.01.003. View

Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K . Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity. 2000; 13(4):539-48. DOI: 10.1016/s1074-7613(00)00053-4. View

Wang T, Scully E, Yin Z, Kim J, Wang S, Yan J . IFN-gamma-producing gamma delta T cells help control murine West Nile virus infection. J Immunol. 2003; 171(5):2524-31. DOI: 10.4049/jimmunol.171.5.2524. View

Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T . Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1. Cell. 1994; 77(6):829-39. DOI: 10.1016/0092-8674(94)90132-5. View

Honda K, Taniguchi T . IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat Rev Immunol. 2006; 6(9):644-58. DOI: 10.1038/nri1900. View

10.

Kollet J, Petro T . IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol Immunol. 2005; 43(6):623-33. DOI: 10.1016/j.molimm.2005.04.004. View

11.

Fragale A, Gabriele L, Stellacci E, Borghi P, Perrotti E, Ilari R . IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression. J Immunol. 2008; 181(3):1673-82. DOI: 10.4049/jimmunol.181.3.1673. View

12.

Schoggins J, Wilson S, Panis M, Murphy M, Jones C, Bieniasz P . A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011; 472(7344):481-5. PMC: 3409588. DOI: 10.1038/nature09907. View

13.

Daffis S, Samuel M, Suthar M, Keller B, Gale Jr M, Diamond M . Interferon regulatory factor IRF-7 induces the antiviral alpha interferon response and protects against lethal West Nile virus infection. J Virol. 2008; 82(17):8465-75. PMC: 2519659. DOI: 10.1128/JVI.00918-08. View

14.

Mehlhop E, Diamond M . Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J Exp Med. 2006; 203(5):1371-81. PMC: 2121216. DOI: 10.1084/jem.20052388. View

15.

Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y, Taniguchi T . Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-beta gene regulatory elements. EMBO J. 1988; 7(11):3397-405. PMC: 454838. DOI: 10.1002/j.1460-2075.1988.tb03213.x. View

16.

Tamura T, Ishihara M, Lamphier M, Tanaka N, Oishi I, Aizawa S . An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature. 1995; 376(6541):596-9. DOI: 10.1038/376596a0. View

17.

Byers A, Kemball C, Moser J, Lukacher A . Cutting edge: rapid in vivo CTL activity by polyoma virus-specific effector and memory CD8+ T cells. J Immunol. 2003; 171(1):17-21. DOI: 10.4049/jimmunol.171.1.17. View

18.

Liu J, Guan X, Ma X . Interferon regulatory factor 1 is an essential and direct transcriptional activator for interferon {gamma}-induced RANTES/CCl5 expression in macrophages. J Biol Chem. 2005; 280(26):24347-55. DOI: 10.1074/jbc.M500973200. View

19.

Szretter K, Samuel M, Gilfillan S, Fuchs A, Colonna M, Diamond M . The immune adaptor molecule SARM modulates tumor necrosis factor alpha production and microglia activation in the brainstem and restricts West Nile Virus pathogenesis. J Virol. 2009; 83(18):9329-38. PMC: 2738257. DOI: 10.1128/JVI.00836-09. View

20.

Szretter K, Daffis S, Patel J, Suthar M, Klein R, Gale Jr M . The innate immune adaptor molecule MyD88 restricts West Nile virus replication and spread in neurons of the central nervous system. J Virol. 2010; 84(23):12125-38. PMC: 2976388. DOI: 10.1128/JVI.01026-10. View